Progerinin    (DrugBank: -)

2 diseases
告示番号疾患名(ページ内リンク)臨床試験数
191ウェルナー症候群1
333ハッチンソン・ギルフォード症候群1

191. ウェルナー症候群 [臨床試験数:3,薬物数:4(DrugBank:3),標的遺伝子数:1,標的パスウェイ数:5
Searched query = "Werner syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 3 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04512963
(ClinicalTrials.gov)
August 24, 20206/8/2020Phase I Study of Progerinin in Healthy VolunteersA Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose (SAD) Study Including a Food Interaction Study, Followed by a Multiple Ascending Dose (MAD) Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Profile of Progerinin in Healthy VolunteersHutchinson-Gilford Progeria Syndrome;Werner SyndromeDrug: Progerinin;Drug: PlaceboPRG Science & Technology Co., Ltd.Amarex Clinical ResearchRecruiting18 Years45 YearsAll56Phase 1United States

333. ハッチンソン・ギルフォード症候群 [臨床試験数:7,薬物数:8(DrugBank:3),標的遺伝子数:4,標的パスウェイ数:6
Searched query = "Hutchinson-Gilford syndrome", "Hutchinson-Gilford progeria syndrome", "HGPS"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 7 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04512963
(ClinicalTrials.gov)
August 24, 20206/8/2020Phase I Study of Progerinin in Healthy VolunteersA Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose (SAD) Study Including a Food Interaction Study, Followed by a Multiple Ascending Dose (MAD) Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Profile of Progerinin in Healthy VolunteersHutchinson-Gilford Progeria Syndrome;Werner SyndromeDrug: Progerinin;Drug: PlaceboPRG Science & Technology Co., Ltd.Amarex Clinical ResearchRecruiting18 Years45 YearsAll56Phase 1United States